Vehicle

A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers

Evaluation of Corneal Endothelium Health Following Articaine Ophthalmic Solution Administration

An Efficacy and Safety Study of DFL24498 in the Treatment of AKC

Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease

Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery

Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

AI-09 In Subjects With Glabellar Lines, GL-101

An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults

Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults

The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy

Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin

Proteolytic Enzyme Induction Within the Human Myocardial Interstitium

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

The Safety and Efficacy of SYD-101 in Children With Myopia

An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED

A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)